Selective Targeting of Non-nuclear Estrogen Receptors with PaPE-1 as a New Treatment Strategy for Alzheimer’s Disease

Alzheimer’s disease (AD) is a multifactorial and severe neurodegenerative disorder characterized by progressive memory decline, the presence of Aβ plaques and tau tangles, brain atrophy, and neuronal loss. Available therapies provide moderate symptomatic relief but do not alter disease progression....

Descripción completa

Detalles Bibliográficos
Autores principales: Wnuk, Agnieszka, Przepiórska, Karolina, Rzemieniec, Joanna, Pietrzak, Bernadeta, Kajta, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591444/
https://www.ncbi.nlm.nih.gov/pubmed/33025361
http://dx.doi.org/10.1007/s12640-020-00289-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591444/
https://www.ncbi.nlm.nih.gov/pubmed/33025361
http://dx.doi.org/10.1007/s12640-020-00289-8

Ejemplares similares